Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

PURPOSE: The analysis of epidermal growth factor receptor (EGFR) mutations in many patients with advanced non-small-cell lung cancer (aNSCLC) has provided the opportunity for successful treatment with specific, targeted EGFR tyrosine kinase inhibitors. However, this therapeutic decision may be chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Arriola, E., Paredes-Lario, A., García-Gomez, R., Diz-Tain, P., Constenla, M., García-Girón, C., Márquez, G., Reck, M., López-Vivanco, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153859/
https://www.ncbi.nlm.nih.gov/pubmed/29623586
http://dx.doi.org/10.1007/s12094-018-1855-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153859/
https://www.ncbi.nlm.nih.gov/pubmed/29623586
http://dx.doi.org/10.1007/s12094-018-1855-y

Ejemplares similares